DAX23.041 -2,3%Est505.574 -2,6%MSCI World4.343 -0,1%Top 10 Crypto8,9200 +2,8%Nas22.388 -1,6%Bitcoin58.639 +2,3%Euro1,1542 ±0,0%Öl106,7 +14,3%Gold5.118 +0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
freenet A0Z2ZZ AIXTRON A0WMPJ E.ON ENAG99 Münchener Rückversicherungs-Gesellschaft 843002 Heidelberg Materials 604700 Tesla A1CX3T Vonovia A1ML7J BioNTech (ADRs) A2PSR2 NEL ASA A0B733 AMD (Advanced Micro Devices) 863186 RWE 703712 Airbus 938914 Rolls-Royce A1H81L TKMS thyssenkrupp Marine Systems TKMS00 Micron Technology 869020
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Sprunghafter Anstieg der Ölpreise: DAX fällt unter 23.000-Punkte-Marke -- Asiens Börsen brechen ein -- Lufthansa, TUI, NVIDIA, Rheinmetall, Novo Nordisk im Fokus
Top News
Die Top-US-Aktien der UBS: Ein Blick in das Portfolio des Schweizer Finanzriesen Die Top-US-Aktien der UBS: Ein Blick in das Portfolio des Schweizer Finanzriesen
Stoxx Europe 50-Wert Novartis-Aktie: Mit dieser Dividende bereitet Novartis Aktionären eine Freude Stoxx Europe 50-Wert Novartis-Aktie: Mit dieser Dividende bereitet Novartis Aktionären eine Freude
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

West Pharmaceutical Services Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
207,70 EUR -3,50 EUR -1,66 %
STU
245,88 USD +1,50 USD +0,61 %
nachbörslich
BTT
finanzen.net zero
West Pharmaceutical Services jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.15,32 Mrd. EUR

KGV40,52Div. Rendite0,31%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN864330

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS9553061055

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolWST

West Pharmaceutical Services Aktien News

DatumMeistgelesen
PR NewswireWest Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
PR NewswireAbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States
PR NewswireWest to Participate in Upcoming Investor Conference
Wer­bungWest Pharmaceutical Services-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireWest Declares Quarterly Dividend
PR NewswireWest Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
PR NewswireWest to Participate in Upcoming Investor Conferences
PR NewswireWest Reports Third-Quarter 2025 Results
PR NewswireWest to Host Third-Quarter 2025 Conference Call
PR NewswireWest to Participate in Upcoming Investor Conferences in September 2025
PR NewswireWest Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance
PR NewswireWest Welcomes Robert McMahon as Incoming Chief Financial Officer
PR NewswireWest to Host Second-Quarter 2025 Conference Call
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireWST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireWST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST
PR NewswireSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireThe Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireThe Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireWST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
PR NewswireContact The Gross Law Firm by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc.(WST)
PR NewswireWST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireThe Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WST
PR NewswireWST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireWST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireWST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireWST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireWest to Participate in Upcoming Investor Conferences
PR NewswireWST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead the West Pharmaceutical Class Action Lawsuit
PR NewswireWest Announces Leadership Changes
PR NewswireWest Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend
PR NewswireWest to Host First-Quarter 2025 Conference Call

West Pharmaceutical Services News

West Pharmaceutical Services News: auf dieser Seite finden Sie alle West Pharmaceutical Services News und Nachrichten zur West Pharmaceutical Services Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch West Pharmaceutical Services News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um West Pharmaceutical Services News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.